Intestinal epithelial barrier and tight junction complexes

The intestinal epithelial barrier and tight junction complexes constitute the critical semi-permeable seal between the intestinal lumen and the underlying mucosal tissues. This complex is composed of transmembrane proteins—primarily claudins, occludin, and junctional adhesion molecules (JAMs)—that interact with intracellular scaffold proteins like zonula occludens (ZO-1, ZO-2, and ZO-3) to link the junction to the actin cytoskeleton (Lee, 2015). Its primary biological function is to regulate the paracellular transport of water, electrolytes, and small nutrients while providing a robust defense against the translocation of luminal antigens, toxins, and commensal bacteria (Fasano, 2011). Pathological "leakiness" or increased permeability of this barrier is a hallmark of several gastrointestinal and systemic diseases, including inflammatory bowel disease (IBD), celiac disease, and metabolic syndrome (Chelakkot et al., 2018). Therapeutic interventions targeting these complexes include zonulin antagonists like larazotide acetate, which aim to stabilize tight junctions and prevent the onset of inflammatory cascades triggered by barrier breach. Additionally, agents like lubiprostone and teduglutide support barrier integrity through chloride channel activation and trophic effects on the intestinal mucosa, respectively (Cuppoletti et al., 2012; Jeppesen, 2012).

Other names

Intestinal mucosal barrierTight junction complexGut barrierZonula occludensParacellular barrierIntestinal tight junctions

Therapeutic strategies targeting this complex involve the antagonism of zonulin to prevent tight junction disassembly, the activation of chloride channels like ClC-2 to promote barrier repair, and the use of GLP-2 analogs to enhance mucosal growth and junctional integrity.